These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 18331797

  • 1. Labeling, characterization, and in vivo localization of a new 90Y-based phosphonate chelate 2,3-dicarboxypropane-1,1-diphosphonic acid for the treatment of bone metastases: Comparison with 99mTc-DPD complex.
    Djokić DDj, Janković DLj, Nikolić NS.
    Bioorg Med Chem; 2008 Apr 15; 16(8):4457-65. PubMed ID: 18331797
    [Abstract] [Full Text] [Related]

  • 2. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.
    Djokić DDj, Janković DLj, Stamenković LLj, Pirmettis I.
    Nucl Med Rev Cent East Eur; 2004 Apr 15; 7(1):1-5. PubMed ID: 15318303
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I, Vanhove C, Revets H, De Baetselier P, Lahoutte T.
    J Nucl Med; 2008 May 15; 49(5):788-95. PubMed ID: 18413403
    [Abstract] [Full Text] [Related]

  • 4. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V, Kumar D, Howman-Giles RB, Little DG.
    Nucl Med Commun; 2007 Feb 15; 28(2):101-7. PubMed ID: 17198350
    [Abstract] [Full Text] [Related]

  • 5. Development of superior bone scintigraphic agent from a series of (99m)Tc-labeled zoledronic acid derivatives.
    Lin J, Qiu L, Cheng W, Luo S, Xue L, Zhang S.
    Appl Radiat Isot; 2012 May 15; 70(5):848-55. PubMed ID: 22381699
    [Abstract] [Full Text] [Related]

  • 6. Preclinical evaluation of DO3P-AME-DO3P: a polyazamacrocyclic methylene phosphonate for diagnosis and therapy of skeletal metastases.
    Tanwar J, Datta A, Tiwari AK, Thirumal M, Chuttani K, Mishra AK.
    Bioconjug Chem; 2011 Feb 16; 22(2):244-55. PubMed ID: 21222430
    [Abstract] [Full Text] [Related]

  • 7. Preparation and in vivo evaluation of 90Y-meso-dimercaptosuccinic acid (90Y-DMSA) for possible therapeutic use: comparison with 99mTc-DMSA.
    Djokić D, Janković D, Nikolić N.
    Cancer Biother Radiopharm; 2009 Feb 16; 24(1):129-36. PubMed ID: 19243255
    [Abstract] [Full Text] [Related]

  • 8. Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative.
    Lin J, Qiu L, Cheng W, Luo S, Ye W.
    Nucl Med Biol; 2011 Jul 16; 38(5):619-29. PubMed ID: 21718936
    [Abstract] [Full Text] [Related]

  • 9. From symmetrical to asymmetrical nitrido phosphino-thiol complexes: a new class of neutral mixed-ligand (99m)Tc compounds as potential brain imaging agents.
    Bolzati C, Benini E, Cavazza-Ceccato M, Cazzola E, Malago E, Agostini S, Tisato F, Refosco F, Bandoli G.
    Bioconjug Chem; 2006 Jul 16; 17(2):419-28. PubMed ID: 16536474
    [Abstract] [Full Text] [Related]

  • 10. Detection of sites of infection in mice using 99mTc-labeled PN(2)S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study.
    Meléndez-Alafort L, Nadali A, Pasut G, Zangoni E, De Caro R, Cariolato L, Giron MC, Castagliuolo I, Veronese FM, Mazzi U.
    Nucl Med Biol; 2009 Jan 16; 36(1):57-64. PubMed ID: 19181269
    [Abstract] [Full Text] [Related]

  • 11. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
    Fonge H, Chitneni SK, Lixin J, Vunckx K, Prinsen K, Nuyts J, Mortelmans L, Bormans G, Ni Y, Verbruggen A.
    Bioconjug Chem; 2007 Jan 16; 18(6):1924-34. PubMed ID: 17929883
    [Abstract] [Full Text] [Related]

  • 12. New bone-seeking agent: animal study of Tc-99m-incadronate.
    Shigematsu M, Shomi S, Iwao H, Ochi H.
    Ann Nucl Med; 2002 Feb 16; 16(1):55-9. PubMed ID: 11922209
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the predicted in vivo behaviour of the Sn(II)-APDDMP complex and the results as studied in a rodent model.
    Zeevaart JR, Jansen DR, Botelho MF, Abrunhosa A, Gomes C, Metello L, Kolar ZI, Krijger GC, Louw WK, Dormehl IC.
    J Inorg Biochem; 2004 Sep 16; 98(9):1521-30. PubMed ID: 15337604
    [Abstract] [Full Text] [Related]

  • 14. Alteration of the organ uptake of the (99m)Tc-radiopharmaceuticals, (99m)Tc-DPD, (99m)Tc-DMSA, (99m)Tc-tin colloid and (99m)Tc-MAA, induced by the applied cytotoxic drugs methotrexate sodium and cyclophosphamide.
    Janković DLj, Djokić DDj.
    Nucl Med Commun; 2005 May 16; 26(5):415-9. PubMed ID: 15838423
    [Abstract] [Full Text] [Related]

  • 15. Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake.
    Bach-Gansmo T, Wien TN, Løndalen A, Halvorsen E.
    Clin Physiol Funct Imaging; 2016 May 16; 36(3):237-41. PubMed ID: 25524030
    [Abstract] [Full Text] [Related]

  • 16. Preparation and biological characterization of isomeric 188Re(V) oxocomplexes with tetradentate S4 ligands derived from meso-dimercaptosuccinic acid for labeling of biomolecules.
    Seifert S, Heinrich T, Jentschel C, Smuda C, Bergmann R, Pietzsch HJ.
    Bioconjug Chem; 2006 May 16; 17(6):1601-6. PubMed ID: 17105241
    [Abstract] [Full Text] [Related]

  • 17. 175Yb labeled polyaminophosphonates as potential agents for bone pain palliation.
    Mathew B, Chakraborty S, Das T, Sarma HD, Banerjee S, Samuel G, Venkatesh M, Pillai MR.
    Appl Radiat Isot; 2004 May 16; 60(5):635-42. PubMed ID: 15082040
    [Abstract] [Full Text] [Related]

  • 18. Modified "4 + 1" mixed ligand technetium-labeled fatty acids for myocardial imaging: evaluation of myocardial uptake and biodistribution.
    Mirtschink P, Stehr SN, Pietzsch HJ, Bergmann R, Pietzsch J, Wunderlich G, Heintz AC, Kropp J, Spies H, Kraus W, Deussen A, Walther M.
    Bioconjug Chem; 2008 Jan 16; 19(1):97-108. PubMed ID: 18052115
    [Abstract] [Full Text] [Related]

  • 19. Novel procedures for preparing 99mTc(III) complexes with tetradentate/monodentate coordination of varying lipophilicity and adaptation to 188Re analogues.
    Seifert S, Künstler JU, Schiller E, Pietzsch HJ, Pawelke B, Bergmann R, Spies H.
    Bioconjug Chem; 2004 Jan 16; 15(4):856-63. PubMed ID: 15264874
    [Abstract] [Full Text] [Related]

  • 20. Bone lesion detection with carrier-added 99mTc-EDTMP in comparison with 99mTc-DPD.
    Fueger BJ, Mitterhauser M, Wadsak W, Ofluoglu S, Traub T, Karanikas G, Dudczak R, Pirich C.
    Nucl Med Commun; 2004 Apr 16; 25(4):361-5. PubMed ID: 15097810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.